|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 4.010 USD | -0.50% |
|
-3.14% | +182.39% |
| 08-19 | Edesa Biotech Launches Public Offering of Common Shares, Warrants | MT |
| 08-13 | Edesa Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 54.18M | - | - | - | - | - |
| 72.26B | |||||
| 60.24B | |||||
| 27.73B | |||||
| 25.73B | - | ||||
| 24.75B | - |
- Stock Market
- Stocks
- EDSA Stock
- Charts Edesa Biotech, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
